Long-read sequencing, a cutting-edge technology in genomics, is being propelled into clinical use with the help of artificial intelligence (AI). Researchers acknowledge support from various funding sources, including EMBL, Wellcome Trust, and several other organizations. Access to crucial patient data was facilitated through Genomics England’s National Genomic Research Library. Carolin Sauer, from the Cortes-Ciriano group at EMBL-EBI, received a prestigious Marie Skłodowska-Curie fellowship for her contributions to this work.By integrating AI with long-read sequencing, researchers are paving the way for more efficient and accurate clinical applications in areas such as oncology and biomedical research. The extensive list of funders highlights the collaborative effort and financial support required for such groundbreaking projects. With the potential to revolutionize genomic research, this advancement underscores the importance of interdisciplinary collaboration and technological innovation in advancing precision medicine. As long-read sequencing becomes increasingly incorporated into clinical practice, the impact on patient care and treatment strategies is poised to significantly improve, ultimately benefiting individuals with various medical conditions.
Read more from miragenews.com
